Cargando…

N(6)-methyladenosine (m(6)A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer

N(6)-methyladenosine (m(6)A) modification has been convincingly identified to be a critical regulator in human cancer. However, the contribution of m(6)A to NSCLC gefitinib resistance is still largely unknown. Here, we screened and identified that m(6)A methyltransferase KIAA1429 was highly expresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jun, Han, Tianci, Tong, Wei, Zhao, Jian, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128911/
https://www.ncbi.nlm.nih.gov/pubmed/34001850
http://dx.doi.org/10.1038/s41420-021-00488-y